TP53 and cancer: After restoring the expression level of p53 in A549 cells, the sensitivity of cancer cells to radiotherapy significantly increased, and significant lipid peroxidation was observed in wild-type p53-expressing A549 cells after adding Nutlin, an inhibitor of MDM2.